# FDA Inspection 1221766 - David W. Mayleben PhD - October 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/david-w-mayleben-phd/b7c4c8c5-84f2-409f-a44c-ba3390e5277e
Source feed: FDA_Inspections

> FDA Inspection 1221766 for David W. Mayleben PhD on October 26, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221766
- Company Name: David W. Mayleben PhD
- Inspection Date: 2023-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 806990 - 2012-11-14](https://www.keypedia.com/records/fda_inspections/david-w-mayleben-phd/b25bee72-994e-4aa9-a230-08d907cf4ea0)

Company: https://www.keypedia.com/companies/david-w-mayleben-phd/a259ab47-d433-46b6-92cf-dd650e0328f3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c